160 related articles for article (PubMed ID: 33061383)
1. Ultrasound Assisted a Peroxisome Proliferator-Activated Receptor (PPAR)γ Agonist-Loaded Nanoparticle-Microbubble Complex to Attenuate Renal Interstitial Fibrosis.
Wei S; Xu C; Zhang Y; Shi Z; Wu M; Yang B
Int J Nanomedicine; 2020; 15():7315-7327. PubMed ID: 33061383
[TBL] [Abstract][Full Text] [Related]
2. Nanomedicines of Hedgehog inhibitor and PPAR-γ agonist for treating liver fibrosis.
Kumar V; Mundra V; Mahato RI
Pharm Res; 2014 May; 31(5):1158-69. PubMed ID: 24249038
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle-mediated local delivery of pioglitazone attenuates bleomycin-induced skin fibrosis.
Kanemaru M; Asai J; Jo JI; Arita T; Kawai-Ohnishi M; Tsutsumi M; Wada M; Tabata Y; Katoh N
J Dermatol Sci; 2019 Jan; 93(1):41-49. PubMed ID: 30655107
[TBL] [Abstract][Full Text] [Related]
4. Small-Sized Cationic miRi-PCNPs Selectively Target the Kidneys for High-Efficiency Antifibrosis Treatment.
Geng X; Zhang M; Lai X; Tan L; Liu J; Yu M; Deng X; Hu J; Li A
Adv Healthc Mater; 2018 Nov; 7(21):e1800558. PubMed ID: 30277665
[TBL] [Abstract][Full Text] [Related]
5. The potential signaling pathway between peroxisome proliferator-activated receptor gamma and retinoic acid receptor alpha in renal interstitial fibrosis disease.
Jiang L; Chen XP; Long YB; Lei FY; Zhou ZQ; Qin YH; Huang WF; Zhou TB
J Recept Signal Transduct Res; 2015; 35(4):258-68. PubMed ID: 25359573
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-γ agonist pioglitazone fails to attenuate renal fibrosis caused by unilateral ureteral obstruction in mice.
Zhang Y; Wang J; Zhou QD; Zhang CH; Li Q; Huang S; Zhan J; Wang K; Liu YY; Xu G
J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):41-47. PubMed ID: 26838738
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone Suppresses Calcium Oxalate Crystal Binding and Oxalate-Induced Oxidative Stress in Renal Epithelial Cells by Promoting PPAR-
Liu YD; Yu SL; Wang R; Liu JN; Jin YS; Li YF; An RH
Oxid Med Cell Longev; 2019; 2019():4826525. PubMed ID: 31781338
[TBL] [Abstract][Full Text] [Related]
8. [Effects of rosiglitazone on the expression of connective tissue growth factor in the pulmonary arteries of rats suffering from fibrosis in lung].
Cui MX; Chen XL; Chen C; Hu XJ; Jin H
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2010 May; 26(2):211-5. PubMed ID: 20684283
[TBL] [Abstract][Full Text] [Related]
9. Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH.
Rashid J; Alobaida A; Al-Hilal TA; Hammouda S; McMurtry IF; Nozik-Grayck E; Stenmark KR; Ahsan F
J Control Release; 2018 Jun; 280():113-123. PubMed ID: 29723610
[TBL] [Abstract][Full Text] [Related]
10. Lipid/PLGA Hybrid Microbubbles as a Versatile Platform for Noninvasive Image-Guided Targeted Drug Delivery.
Chen Y; Liang Y; Jiang P; Li F; Yu B; Yan F
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41842-41852. PubMed ID: 31633326
[TBL] [Abstract][Full Text] [Related]
11. Asiatic acid prevents renal fibrosis in UUO rats via promoting the production of 15d-PGJ2, an endogenous ligand of PPAR-γ.
Zhang ZH; He JQ; Zhao YY; Chen HC; Tan NH
Acta Pharmacol Sin; 2020 Mar; 41(3):373-382. PubMed ID: 31705123
[TBL] [Abstract][Full Text] [Related]
12. Dual soluble epoxide hydrolase inhibitor/PPAR-γ agonist attenuates renal fibrosis.
Stavniichuk A; Hye Khan MA; Yeboah MM; Chesnik MA; Jankiewicz WK; Hartmann M; Blöcher R; Kircher T; Savchuk O; Proschak E; Imig JD
Prostaglandins Other Lipid Mediat; 2020 Oct; 150():106472. PubMed ID: 32569747
[TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone causes cardiotoxicity via peroxisome proliferator-activated receptor γ-independent mitochondrial oxidative stress in mouse hearts.
He H; Tao H; Xiong H; Duan SZ; McGowan FX; Mortensen RM; Balschi JA
Toxicol Sci; 2014 Apr; 138(2):468-81. PubMed ID: 24449420
[TBL] [Abstract][Full Text] [Related]
14. [Protection of rosiglitazone against renal interstitial lesion and its mechanism].
Lin Q; Gu Y; Ma J; Lin SY
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1618-24. PubMed ID: 16185530
[TBL] [Abstract][Full Text] [Related]
15. Short Hairpin RNA Knockdown of Connective Tissue Growth Factor by Ultrasound-Targeted Microbubble Destruction Improves Renal Fibrosis.
Wei S; Xu C; Rychak JJ; Luong A; Sun Y; Yang Z; Li M; Liu C; Fu N; Yang B
Ultrasound Med Biol; 2016 Dec; 42(12):2926-2937. PubMed ID: 27597128
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome Proliferator-Activated Receptor γ Agonist Rosiglitazone Protects Blood-Brain Barrier Integrity Following Diffuse Axonal Injury by Decreasing the Levels of Inflammatory Mediators Through a Caveolin-1-Dependent Pathway.
Zhao Y; Wei X; Song J; Zhang M; Huang T; Qin J
Inflammation; 2019 Jun; 42(3):841-856. PubMed ID: 30488141
[TBL] [Abstract][Full Text] [Related]
17. A pH-Responsive System Based on Fluorescence Enhanced Gold Nanoparticles for Renal Targeting Drug Delivery and Fibrosis Therapy.
Lai X; Geng X; Tan L; Hu J; Wang S
Int J Nanomedicine; 2020; 15():5613-5627. PubMed ID: 32884257
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, in a mouse allergic asthma model is not associated with the recruitment or generation of Foxp3-expressing CD4
Maślanka T; Otrocka-Domagała I; Zuśka-Prot M; Gesek M
Eur J Pharmacol; 2019 Apr; 848():30-38. PubMed ID: 30710547
[TBL] [Abstract][Full Text] [Related]
19. Renal tubular epithelium-targeted peroxisome proliferator-activated receptor-γ maintains the epithelial phenotype and antagonizes renal fibrogenesis.
Zhao M; Chen Y; Ding G; Xu Y; Bai M; Zhang Y; Jia Z; Huang S; Zhang A
Oncotarget; 2016 Oct; 7(40):64690-64701. PubMed ID: 27602490
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound/microbubble-mediated targeted delivery of anticancer microRNA-loaded nanoparticles to deep tissues in pigs.
Di Ianni T; Bose RJC; Sukumar UK; Bachawal S; Wang H; Telichko A; Herickhoff C; Robinson E; Baker S; Vilches-Moure JG; Felt SA; Gambhir SS; Paulmurugan R; Dahl JD
J Control Release; 2019 Sep; 309():1-10. PubMed ID: 31326463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
